Jazz Pharmaceuticals Plc (JAZZ)
235.67
+2.66
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
235.53
-0.14
(-0.06%)
After-Hours: 20:00
Jazz Pharmaceuticals Market Cap : 15.27B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 15.27B |
| October 01, 2026 | 15.10B |
| September 30, 2026 | 15.00B |
| September 29, 2026 | 15.06B |
| September 28, 2026 | 15.44B |
| September 25, 2026 | 15.42B |
| September 24, 2026 | 15.31B |
| September 23, 2026 | 15.22B |
| September 22, 2026 | 15.59B |
| September 21, 2026 | 15.65B |
| September 18, 2026 | 15.60B |
| September 17, 2026 | 15.80B |
| September 16, 2026 | 15.78B |
| September 15, 2026 | 15.61B |
| September 14, 2026 | 15.93B |
| September 11, 2026 | 15.93B |
| September 10, 2026 | 15.58B |
| September 09, 2026 | 15.64B |
| September 08, 2026 | 15.56B |
| September 04, 2026 | 15.99B |
| September 03, 2026 | 16.04B |
| September 02, 2026 | 15.91B |
| September 01, 2026 | 15.79B |
| August 31, 2026 | 16.24B |
| August 28, 2026 | 15.85B |
| Date | Value |
|---|---|
| August 27, 2026 | 16.27B |
| August 26, 2026 | 16.15B |
| August 25, 2026 | 16.86B |
| August 24, 2026 | 16.49B |
| August 21, 2026 | 16.48B |
| August 20, 2026 | 16.12B |
| August 19, 2026 | 16.34B |
| August 18, 2026 | 16.40B |
| August 17, 2026 | 16.09B |
| August 14, 2026 | 15.87B |
| August 13, 2026 | 15.93B |
| August 12, 2026 | 16.13B |
| August 11, 2026 | 16.07B |
| August 10, 2026 | 16.62B |
| August 07, 2026 | 16.63B |
| August 06, 2026 | 16.63B |
| August 05, 2026 | 16.95B |
| August 04, 2026 | 16.95B |
| August 03, 2026 | 16.30B |
| July 31, 2026 | 16.39B |
| July 30, 2026 | 16.74B |
| July 29, 2026 | 16.05B |
| July 28, 2026 | 16.11B |
| July 27, 2026 | 16.02B |
| July 24, 2026 | 15.92B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Avadel Pharmaceuticals Plc | 2.104B |
| GH Research Plc | 1.575B |
| Cosmo NV | 1.085B |
| Axsome Therapeutics, Inc. | 9.375B |
| Eli Lilly & Co. | 1.076T |
Market Cap Related Metrics
| PE Ratio | 16.25 |
| PS Ratio | 3.336 |
| Price to Book Value | 3.180 |
| Price to Free Cash Flow | 10.18 |
| Price | 235.67 |
| Earnings Yield | 6.15% |
| Operating PE Ratio | 16.07 |
| Normalized PE Ratio | 14.15 |